Skip to main content
. 2021 Dec 16;13(12):2167. doi: 10.3390/pharmaceutics13122167
API Active pharmacologic ingredient
BBB Blood–brain barrier
CGMP Current Good Manufacturing Practices
CNS Central nervous system
GBM Glioblastoma
IDH Isocitrate dehydrogenase
MRI Magnetic resonance imaging
POH Perillyl alcohol
RT Radiation therapy
TMZ Temozolomide